Treatment of Stiff-Person Syndrome, Myoclonus & Painful-Legs ...

Treatment of Stiff-Person Syndrome, Myoclonus & Painful-Legs ...

Treatment of Hyperkinetic Movement Disorders: Part II Tim McDowell Stiff-Person Syndrome Combo therapy of benzodiazepines and baclofen in high dosage. These drugs may decrease the superimposed severe spasms, but are not entirely effective in controlling the background sustained continuous muscle hyperactivity

Sodium valproate and tizanidine have also been reported to be beneficial Intrathecal baclofen has been used Patients have been reported to respond to steroid therapy, intravenous human immunoglobulin (IVIg) infusions and plasmapheresis, but others have gained no benefit from plasmapheresis. A double-blind, placebo-controlled study documented the value of IVIg Another study has shown improvement in quality of life with IVIg Rituximab has been reported to be useful in a few patients

Baclofen precise mechanism of action of baclofen is not fully known. Can inhibit monosynaptic and polysynaptic reflexes at the spinal level, ? actions at supraspinal sites baclofen is an analog of the putative inhibitory neurotransmitter gamma-aminobutyric acid (GABA) (not proven that this is its mechanism of action) Has CNS depressant properties Rapidly and extensively absorbed and eliminated. Can be

reduced with increasing doses. Kidney excretion, large intersubject variation in absorption and/or elimination. Baclofen Oral: 5 mg 3 times/day, may increase 5 mg/dose every 3 days to a maximum of 80 mg/day Intrathecal: Test dose: 50-100 mcg, doses >50 mcg should be given in 25 mcg

increments, separated by 24 hours. A screening dose of 25 mcg may be considered in very small patients. Patients not responding to screening dose of 100 mcg should not be considered for chronic infusion/implanted pump. Maintenance: After positive response to test dose, a maintenance intrathecal infusion can be administered via an implanted intrathecal pump. Initial dose via pump: Infusion at a 24-hourly rate dosed at twice the test dose. Avoid abrupt discontinuation.

Tizanidine Tizanidine hydrochloride alpha-2-adrenergic agent short-acting drug for the management of spasticity. should be reserved for those daily activities and times when relief of spasticity is most important common adverse events make it prudent to begin treatment with single oral doses of 4 mg. Increase the dose gradually (2 mg to 4 mg steps) to optimum effect The dose can be repeated at 6 to 8 hour intervals, as

needed, to a maximum of three doses in 24 hours. The total daily dose should not exceed 36 mg. Tizanidine Side effects: dizziness, somnolence, weakness, Strong interaction with ciprofloxacin, do not use together Ciprofloxacin decreases the metabolism of tizanidine significantly

Caution with elderly (anticholinergic properties) Monitor LFTS at baseline, 1,3,6 months, BP and renal function Pregnancy risk C Myoclonus Myoclonus

The drugs used to treat myoclonus generally possess anticonvulsant properties), usually by enhancing gammaaminobutyric (GABA) inhibitory activity. Electrophysiologic evidence suggests that antimyoclonic drugs may exert different actions on the sequence of events responsible for myoclonus, at least for those concerned with cortical myoclonus. Some drugs which decrease cortical myoclonus increase the size of the giant sensory evoked potential, while others have the opposite effect. Myoclonus thus often responds best to a

combination of drugs Myoclonus Contd Clonazepam (Rivotril) Start at 1.5mg daily, in three doses, go up to 15mg. Taper off Side effects include drowsiness, dizziness, behavioral Watch for delirium in elderly

Can increase phenytoin levels Carbamazepine can increase metabolism Pregnancy Risk D, not recommended for breastfeeding Monitor CBC, LFTs Painful Legs-Moving-Toes Very difficult to treat; some success has been claimed with the following: Nerve blocks, guanethidine infusions, transcutaneous electrical nerve stimulation Anticonvulsants, antidepressants, adenosine

It is the pain that causes the major disability, and unfortunately, this is very difficult to treat. A few patients have responded to sympathetic blockade, but in the majority, this is ineffective. A course of guanethidine blocks into the affected limb is worth trying. Transcutaneous electrical nerve stimu-lation applied to the leg or foot might help the pain. Carbamazepine, diphenylhydantoin, amitriptyline, and pheno-thiazines occasionally help. There is one report of adenosine being useful. One patient responded to gabapentin 600 mg three times per day. Epidural block may be helpful, as may epidural spinal cord stimulation.

Wilsons Disease Paroxysmal Dyskinesias Paroxysmal Kinesogenic: anticonvulsants Paroxysmal Nonkinesogenic: Clonazepam, other benzos, acetazolamide,

antimuscarinics Paroxysmal Exertional: acetazolamide,antimuscarinics, benzodiazepines Episodic Ataxia Acetazolamide should be tried Most effective in EA2 (?50-75%, no RCTs), also

EA3, EA5, and EA6 Can also try anticonvulsants for EA1 Acetazolamide

Aka Diamox Carbonic Anhydrase Inhibitor Dosing 250-1000mg/day, twice daily dosing Side Effects: Dizziness, anorexia, metallic taste in mouth, numbness and tingling in hands, feet and mouth, kidney stones Careful for sulfa allergies Monitor electrolytes Pregnancy Category C

RLS Augmentation: Onset of symptoms earlier or extension to arms/trunk. Difficult to treat, see Refractroy RLSabove Suggested Reference

Recently Viewed Presentations

  • Dissertation proposal -

    Dissertation proposal -

    Development of consensual response strategies. Cardinal Rules of Risk Communication. Accept the public as a legitimate partner. Listen to the audience. Be honest and transparent. Collaborate with credible sources. Meet the needs of the media. Speak clearly and with compassion....
  • Autonomy Requirements Tester (ART): Reusing a CFS Test

    Autonomy Requirements Tester (ART): Reusing a CFS Test

    ART Team Members. Dr. Carrol Thronesbery. Expertise in Human System Integration & Human Machine Interface. Work mainly focuses on applying human factors guidelines including displays, controls and testing procedures for autonomous systems
  • The Thesis Statement

    The Thesis Statement

    The Thesis Statement The most important sentence. Ever. (at least in your essay) The Thesis of an essay… is the controlling idea of the paper Is the road map for the organization for the paper Has three parts: Topic Opinion...
  • Traffic Incident Management (TIM) Gap Analysis Outreach Briefing

    Traffic Incident Management (TIM) Gap Analysis Outreach Briefing

    Traffic Incident Management Gap Analysis Outreach Briefing - Executive Decision Makers As this is a transition slide, may wish to say "and now we will discuss the gaps that were identified in the national TIM program analysis" and then quickly...
  • Implicit Bias

    Implicit Bias

    IMPLICIT BIAS AT WORK. AFFINITY BIAS. E.g.: hiring people who remind us of ourselves, even if other applicants more qualified. Can stem from internal referrals. Also affects assignments and opportunities . CONFIRMATION BIAS. The tendency to search for or remember...
  • Diapositive 1 - Infectiologie

    Diapositive 1 - Infectiologie

    Josiane Warszawski,Véronique Goulet Dépistage de l'infection à Chlamydia trachomatis dans un Centre de planification familiale et d'orthogénie, Bordeaux, France, 2005 Bertille de Barbeyrac 1, Karine Tilatti2, Sophie Raherison1, Claudine Mathieu2, Sandrine Frantz-Blancpain2, Maïthé Clerc1, Véronique Goulet3, Christiane Bébéar1 ...
  • The Science and Engineering of Materials, 4th ed Donald R ...

    The Science and Engineering of Materials, 4th ed Donald R ...

    Eventually, the copper atoms are randomly distributed throughout the nickel * Figure 5.11 Diffusion mechanisms in material: (a) vacancy or substitutional atom diffusion and (b) interstitial diffusion ©2003 Brooks/Cole, a division of Thomson Learning, Inc. Thomson Learning™ is a trademark...
  • ASA PM Workshopscheduling

    ASA PM Workshopscheduling

    ASA PM Workshopscheduling. Thursday March 2nd, 2017. My goal for this class is to review and discuss various types of schedules and process that are used and issued by the GC and subcontractors.